Brand Name

Ecoza

Generic Name
Econazole
View Brand Information
FDA approval date: November 26, 2002
Classification: Azole Antifungal
Form: Cream, Aerosol

What is Ecoza (Econazole)?

Ecoza topical foam, 1%, is indicated for the treatment of interdigital tinea pedis caused by Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum in patients 12 years of age and older. Ecoza is an azole antifungal indicated for the treatment of interdigital tinea pedis caused by Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum in patients 12 years of age and older.

Approved To Treat

Top Global Experts

Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances

Related Clinical Trials

There is no clinical trials being done for this treatment

Related Latest Advances

Repurposing azole antifungals as rapid bactericidal, membrane-disruptive therapeutics against Clostridioides difficile.
Repurposing azole antifungals as rapid bactericidal, membrane-disruptive therapeutics against Clostridioides difficile.
Journal: Microbiology spectrum
Published: May 18, 2026
Integrated clinical and computational data-based repurposing of econazole as a novel autophagic activator in ULK1-related Parkinson disease.
Integrated clinical and computational data-based repurposing of econazole as a novel autophagic activator in ULK1-related Parkinson disease.
Journal: Autophagy
Published: May 11, 2026
Development and Application of an UPLC-MS/MS Method for Simultaneous Quantification of Abemaciclib and Tamoxifen with Their Active Metabolites in Rat Plasma: Application to a Pharmacokinetic Study.
Development and Application of an UPLC-MS/MS Method for Simultaneous Quantification of Abemaciclib and Tamoxifen with Their Active Metabolites in Rat Plasma: Application to a Pharmacokinetic Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 09, 2026
View All Latest Advances